T1	HMM 33 71	relapsing-remitting multiple sclerosis
T2	HMM 1151 1178	was annualised relapse rate
T3	HMM 1496 1523	The annualised relapse rate
T4	HMM 1766 1787	patients were relapse
T5	HMM 2064 2125	group had serious adverse events excluding multiple sclerosis
T6	HMM 2199 2208	a serious
T7	HMM 2519 2559	treatment option for relapsing-remitting
